Tech Company Financing Transactions

NeuroVia Funding Round

Novartis Venture Fund, Sanofi-Genzyme BioVentures and BioMed Ventures participated in a $14 million Series A funding round for NeuroVia. The round was announced on 7/21/2017.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

332 Bdwy. 1
Cambridge, MA 02139
USA

Phone

(415) 254-2232

Website

Email Address

Not Recorded

Overview

NeuroVia, Inc. is committed to addressing unmet medical needs in neurological diseases with the primary goal to arrest the onset of devastating neurological deficits associated with X-ALD.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Co-Founder

Thomas Scanlan

        

Browse more venture capital transactions:

Prev: 7/21/2017: Trevi Therapeutics venture capital transaction
Next: 7/21/2017: Graphcore venture capital transaction

Share this article

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary